Amgen Inc. (Nasdaq: AMGN) announced reaching a goal for a bone drug treatment for breast cancer patients sending the stock price soaring $8.22 to $60.45.
Amgen Reports Upbeat Results For Bone Treatment
July 08, 2009 at 11:09 AM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.